Japan Hospice Holdings Inc.

As of June 30, 2026, Japan Hospice Holdings Inc. carries a market capitalization of 4.44B, placing it among publicly traded companies globally. Its enterprise value stands at 15.59B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Japan Hospice Holdings Inc.'s next confirmed earnings release is scheduled for November 13, 2026.

As of June 30, 2026, Japan Hospice Holdings Inc. has 8.48M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Japan Hospice Holdings Inc. maintains a current ratio of 1.39, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Japan Hospice Holdings Inc.'s stock has declined approximately 66.72% over the past 52 weeks. The 50-day moving average sits at 488.44, while the 200-day moving average is 702.02.

As of June 30, 2026, Japan Hospice Holdings Inc. holds 1.93B in cash and equivalents against 13.08B in total debt, resulting in a net debt position of 2.34B. Total book value stands at 3.66B, with working capital of 1.22B providing operational flexibility.